$160,000 of EXPEDIA GROUP lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"None"
You can find more data on corporate lobbying on Quiver Quantitative.
EXPE Insider Trading Activity
EXPE insiders have traded $EXPE stock on the open market 34 times in the past 6 months. Of those trades, 0 have been purchases and 34 have been sales.
Here’s a breakdown of recent trading of $EXPE stock by insiders over the last 6 months:
- ARIANE GORIN (Chief Executive Officer) has made 0 purchases and 3 sales selling 57,244 shares for an estimated $10,368,989.
- DARA KHOSROWSHAHI has made 0 purchases and 24 sales selling 50,000 shares for an estimated $8,927,349.
- ROBERT J DZIELAK (Chief Legal Officer & Sec'y) has made 0 purchases and 4 sales selling 15,405 shares for an estimated $3,031,312.
- LANCE A SOLIDAY (SVP & Chief Accounting Officer) has made 0 purchases and 3 sales selling 8,418 shares for an estimated $1,541,227.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EXPE Hedge Fund Activity
We have seen 404 institutional investors add shares of EXPE stock to their portfolio, and 391 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VICTORY CAPITAL MANAGEMENT INC added 1,232,693 shares (+87.0%) to their portfolio in Q4 2024, for an estimated $229,687,686
- BOSTON PARTNERS removed 979,791 shares (-80.5%) from their portfolio in Q4 2024, for an estimated $182,564,457
- PAR CAPITAL MANAGEMENT INC removed 878,765 shares (-27.0%) from their portfolio in Q4 2024, for an estimated $163,740,282
- PACER ADVISORS, INC. removed 873,747 shares (-26.9%) from their portfolio in Q4 2024, for an estimated $162,805,278
- FISHER ASSET MANAGEMENT, LLC removed 762,297 shares (-45.1%) from their portfolio in Q4 2024, for an estimated $142,038,800
- BALYASNY ASSET MANAGEMENT L.P. added 660,934 shares (+inf%) to their portfolio in Q4 2024, for an estimated $123,151,832
- VALUEACT HOLDINGS, L.P. removed 590,200 shares (-22.6%) from their portfolio in Q4 2024, for an estimated $109,971,966
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
EXPE Analyst Ratings
Wall Street analysts have issued reports on $EXPE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 12/18/2024
To track analyst ratings and price targets for EXPE, check out Quiver Quantitative's $EXPE forecast page.
EXPE Price Targets
Multiple analysts have issued price targets for $EXPE recently. We have seen 6 analysts offer price targets for $EXPE in the last 6 months, with a median target of $178.0.
Here are some recent targets:
- Ken Gawrelski from Wells Fargo set a target price of $143.0 on 04/07/2025
- Trevor Young from Barclays set a target price of $166.0 on 01/13/2025
- Tom White from D.A. Davidson set a target price of $190.0 on 11/18/2024
- Leo Horowitz from Deutsche Bank set a target price of $192.0 on 11/08/2024
- Mark Mahaney from Evercore ISI set a target price of $210.0 on 11/08/2024
- Ross Sandler from Piper Sandler set a target price of $153.0 on 11/08/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
